Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Apr 19, 2024 07:13 ET
Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapy
Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that dosing is complete in the second cohort of its...
Apr 19, 2024 07:11 ET
Huize Holding Limited Files 2023 Annual Report on Form 20-F
Huize Holding Limited, (“Huize,” the “Company” or “we”) (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance carriers and distribution partners digitally through data-driven and AI-powered solutions in China,...
Apr 19, 2024 07:00 ET
Merlin Chain Launches MERL: A Major Leap Forward in Bitcoin Layer 2 Solutions
Merlin Chain, the largest Bitcoin Layer 2 protocol by total value locked (TVL), is thrilled to announce the launch of its native token, $MERL. As a significant enhancement to the Bitcoin network, Merlin Chain facilitates the rapid growth of...
Apr 19, 2024 07:00 ET
Balchem Corporation Announces Quarterly Conference Call for First Quarter Financial Results on May 3, 2024
Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, May 3, 2024, at 11:00 AM Eastern Time (ET) to review first quarter results. Ted Harris, Chairman of the Board, President and CEO, and Martin...
Apr 19, 2024 07:00 ET
ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it has again successfully defended against opposition filed against a key patent for its ADAR-mediated RNA...
Apr 19, 2024 07:00 ET
Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®
Data presented in a platform session at the Annual Meeting of the American Academy of Neurology in Denver, Colorado - NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a...
Apr 19, 2024 06:41 ET
Giambattista Valli dazzles Barcelona during the Bridal Night
The most exclusive fashion show of the Barcelona Bridal Fashion Week charmed over 450 guests last night who enjoyed a unique show in the historic building of the Llotja de Mar. The Maison Giambattista Valli exclusively celebrated the runway debut...
Apr 19, 2024 06:31 ET
WOO X Research revises BTC price prediction and Q2 industry outlook, one day before BTC Halving
WOO X Research, a dedicated division of global crypto exchange WOO X, dedicated to impartial crypto market analysis, has revised its Q2 predictions one day before the imminent Bitcoin halving. In its latest report titled "WOO X Research Q1 Summary...
Apr 19, 2024 06:10 ET
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today a long-term agreement with a strategic partner to further enhance access to...
Apr 19, 2024 06:00 ET
Vaccinologists Keith Klugman and Shabir Madhi Awarded Sabin’s Prestigious Gold Medal; Infectious Diseases Epidemiologist Nicole Basta Receives Rising Star Award
The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award to infectious diseases epidemiologist Nicole Elaine Basta at a ceremony in...
Apr 19, 2024 05:00 ET
Private Bancorp of America, Inc. Announces Strong Net Income and Earnings Per Share for First Quarter 2024
Private Bancorp of America, Inc. (OTCQX: PBAM), (“Company”) and CalPrivate Bank (“Bank”) announced unaudited financial results for the first fiscal quarter ended March 31, 2024. The Company reported net income of $7.9 million, or $1.36 per diluted...
Apr 19, 2024 04:55 ET
Technip Energies Selected by Viridor to perform FEED on the Runcorn Energy-from-Waste Carbon Capture Project in the United Kingdom
Technip Energies (PARIS:TE) has been awarded a Front-End Engineering Design (FEED) contract by Viridor for the Carbon Capture and Storage (CCS) project at one of the United Kingdom’s largest Energy-from-Waste facilities in Runcorn, United Kingdom....
Apr 19, 2024 04:45 ET
Himax Joins Forces with E Ink to Revolutionize Smart Retail with Premier of WiseEye™ AI at 2024 Touch Taiwan
Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced a collaboration with E Ink Holdings Inc. (“E Ink"), a pioneer and...
Apr 19, 2024 04:07 ET
Amarna Therapeutics announces appointment of Aurelia Caparrós as new Chief Business Officer
Leiden, The Netherlands, 19 April 2024 – Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare and prevalent diseases,  including Type 1 Diabetes Mellitus, today announces the...
Apr 19, 2024 04:00 ET
CC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that The Chemours Company Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) and certain of its...
Apr 19, 2024 04:00 ET
FOXF INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fox Factory Holding Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Fox Factory Holding Corp. (“Fox Factory” or “the Company”) (NASDAQ: FOXF) and certain...
Apr 19, 2024 04:00 ET
INVZ INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Innoviz Technologies Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Innoviz Technologies Ltd. (“Innoviz” or “the Company”) (NASDAQ: INVZ) and certain of...
Apr 19, 2024 01:00 ET
Addex to Present at the Swiss Biotech Day 2024
Geneva, Switzerland, April 19, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug development, announced today that CEO, Tim Dyer, will present at the Swiss Biotech...
Apr 19, 2024 01:00 ET
Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer
Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced the initiation of the Phase 2 clinical trial VB-C-04. The trial evaluates VB10.16,...
Apr 19, 2024 01:00 ET
Sodexo announces solid H1 Fiscal 2024 results
Issy-les-Moulineaux, April 19, 2024 Sodexo (Euronext Paris FR 0000121220-OTC: SDXAY) Sodexo announces solid H1 Fiscal 2024 results Organic Revenue growth +8.5%Underlying operating profit +16.9% at constant currencies, margin up +40 bpsFiscal...